Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Aarhus – page 25

631 clinical trials in Aarhus, Denmark across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Aarhus at a glance
631
clinical trials
  • Research sites5
Type of trial
Recruitment status
Quick filters

631 trials in Aarhus

Open in trial search

Group B streptococcus neonatal sepsis

Not yet recruiting

Safety and Immune Response of GBS‑NN/NN2 Vaccine in Pregnant Women and Their Infants to Prevent Group B Streptococcus Infection

Investigational
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Sponsor:Minervax ApS

Idiopathic pulmonary fibrosis

Not yet recruiting

Randomized Phase 3 Study of Deupirfenidone (LYT‑100) versus Pirfenidone in Adults with Idiopathic Pulmonary Fibrosis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Deupirfenidone
  • Sponsor:Puretech Lyt 100 Inc.

Non-small cell lung cancer

Not yet recruiting

Phase II Randomized Trial of Adjuvant Durvalumab Immunotherapy After Neoadjuvant Chemoimmunotherapy in Patients With Resectable Non‑Small Cell Lung Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Oslo University Hospital HF

Monogenic diabetes

Not yet recruiting

Effect of semaglutide added to sulfonylurea on blood sugar in adults with HNF1A‑MODY and HNF4A‑MODY

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Steno Diabetes Center Copenhagen

Mantle cell lymphoma+2

Not yet recruiting

Zoledronic acid prophylaxis for glucocorticoid‑induced osteoporosis in adult lymphoma patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Zoledronic Acid
  • Sponsor:Aalborg University Hospital

Post procedural infection

Not yet recruiting

Cloxacillin and drug combination for prevention of postoperative infections in patients undergoing head and neck reconstructive surgery

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Amoxicillin
  • Sponsor:Region Midtjylland

Optic ischaemic neuropathy

Not yet recruiting

Efficacy and Safety of Intranasal Cenegermin in Adults with Non‑Arteritic Anterior Ischemic Optic Neuropathy (NAION)

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cenegermin
  • Sponsor:Dompe' Farmaceutici S.p.A.

A Phase III study of AZD0120 with drug combination versus standard therapy in adults with newly diagnosed multiple myeloma not eligible for stem cell transplant

Not yet recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:AZD0120
  • Sponsor:AstraZeneca AB

Pemphigoid

Not yet recruiting

Safety and Tolerability of Lebrikizumab in Adults with Newly Diagnosed Bullous Pemphigoid

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lebrikizumab
  • Sponsor:Region Midtjylland

Sepsis+3

Not yet recruiting

Comparison of ampicillin plus gentamicin versus piperacillin/tazobactam for empirical treatment of hospitalized patients with community‑acquired infection

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ampicillin Sodium
  • Sponsor:Region Hovedstaden

Tonsillitis

Not yet recruiting

Intravenous benzathine benzylpenicillin added to oral phenoxymethylpenicillin for relief in adults with acute tonsillitis, peritonsillar phlegmon and abscess

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Region Midtjylland

Small cell lung cancer limited stage

Not yet recruiting

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Aarhus

What the registry says about research in the country

01 Respiratory & Pulmonary Research

Clinical investigations focusing on idiopathic pulmonary fibrosis and innovative treatments for respiratory conditions. Studies include assessment of vital capacity changes and evaluation of new therapeutic approaches.

  • Pulmonary Function Testing
  • Respiratory Disease Management
  • Treatment Efficacy Studies
02 Oncology & Cancer Research

Groundbreaking trials examining treatments for endometrial carcinoma and hepatocellular carcinoma, utilizing advanced imaging techniques and combination therapies.

  • Immunotherapy Combinations
  • Early Cancer Detection
  • Targeted Therapies
03 Neurological Disorders

Studies investigating amyotrophic lateral sclerosis and neurological conditions using innovative MRI techniques and metabolic imaging. Research includes assessment of chronic inflammatory demyelinating polyneuropathy.

  • Metabolic Imaging
  • Neurodegeneration
  • Treatment Response
04 Preventive Medicine

Vaccination studies targeting meningococcal infection and respiratory syncytial virus, with particular focus on maternal and infant health protection.

  • Vaccine Development
  • Immunogenicity Assessment
  • Maternal-Infant Protection
Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.